Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine/Ara-C and RIC Allo-SCT for Primary Treatment Failure AML
NCT01188174Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Jul 2010
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by CHU de Nantes. Started Jul 2010; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01188174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188174.